A positive feedback between activated extracellularly regulated kinase and cyclooxygenase/lipoxygenase maintains proliferation and migration of breast cancer cells

Endocrinology

Volumn 150, Issue 4, 2009, Pages 1607-1616

  You, Jiacong ^a   Mi, Da ^a   Zhou, Xiaolei ^a   Qiao, Ling ^a   Zhang, Hang ^a   Zhang, Xiaodong ^a   Ye, Lihong ^a  

^a NANKAI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CYCLIN D1; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; GUANINE NUCLEOTIDE BINDING PROTEIN; LIPOXYGENASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHOLIPASE C; PROTEIN KINASE C; SURVIVIN;

ARACHIDONIC ACID METABOLISM; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; METASTASIS; POSITIVE FEEDBACK; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

BETA CATENIN; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CYCLIN D1; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLAVONOIDS; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; HUMANS; IMMUNOBLOTTING; LIPOXYGENASE; MICROTUBULE-ASSOCIATED PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROTEIN KINASE C; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TYPE C PHOSPHOLIPASES;

EID: 63849232779     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-0616     Document Type: Article

References (48)

1. Yoeli-Lerner M, Yiu GK, Rabinovitz I, Erhardt P, Jauliac S, Toker A 2005 Akt blocks breast cancer cell motility and invasion through the transcription factor NFAT. Mol Cell [Erratum (2006) 22:145] 20:539-550
2. Azios NG, Krishnamoorthy L, Harris M, Cubano LA, Cammer M, Dharmawardhane SF 2007 Estrogen and resveratrol regulate Rac and Cdc42 signaling to the actin cytoskeleton of metastatic breast cancer cells. Neoplasia 9:147-158
3. Miller SL, Antico G, Raghunath PN, Tomaszewski JE, Clevenger CV 2007 Nek3 kinase regulates prolactin-mediated cytoskeletal reorganization and mo- tility of breast cancer cells. Oncogene 26:4668-4678
4. Sossey-Alaoui K, Safina A, Li X, Vaughan MM, Hicks DG, Bakin AV, Cowell JK 2007 Down-regulation of WAVE3, a metastasis promoter gene, inhibits invasion and metastasis of breast cancer cells. Am J Pathol 170:2112-2121
5. Qiao M, Iglehart JD, Pardee AB 2007 Metastatic potential of 21T human breast cancer cells depends on Akt/protein kinase B activation. Cancer Res 67:5293-5299
6. Imanishi Y, Hu B, Jarzynka MJ, Guo P, Elishaev E, Bar-Joseph I, Cheng SY 2007 Angiopoietin-2 stimulates breast cancer metastasis through the α(5)β(1) integrin-mediated pathway. Cancer Res 67:4254 -4263
7. Datta D, Flaxenburg JA, Laxmanan S, Geehan C, Grimm M, Waaga-Gasser AM, Briscoe DM, Pal S 2006 Ras-induced modulation of CXCL10 and its receptor splice variant CXCR3-B in MDA-MB-435 and MCF-7 cells: relevance for the development of human breast cancer. Cancer Res 66:9509 -9518
8. SinghK, MogareD, GiridharagopalanRO, GogirajuR, PandeG, Chattopadhyay S 2007 p53 target gene SMAR1 is dysregulated in breast cancer: its role in cancer cell migration and invasion. PLoS ONE 2:e660
9. Giehl K, Imamichi Y, Menke A 2007 Smad4-independent TGF-β signaling in tumor cell migration. Cells Tissues Organs 185:123-130
10. Krueger JS, Keshamouni VG, Atanaskova N, Reddy KB 2001 Temporal and quantitative regulation of mitogen-activated protein kinase (MAPK) modulates cell motility and invasion. Oncogene 20:4209 -4218
11. Honma N, Genda T, Matsuda Y, Yamagiwa S, Takamura M, Ichida T, Aoyagi Y 2006 MEK/ERK signaling is a critical mediator for integrin-induced cell scattering in highly metastatic hepatocellular carcinoma cells. Lab Invest 86:687-696
12. Hayashi T, Nishiyama K, Shirahama T 2006 Inhibition of 5-lipoxygenase pathway suppresses the growth of bladder cancer cells. Int J Urol 13:1086-1091
13. Hong J, Bose M, Ju J, Ryu JH, Chen X, Sang S, Lee MJ, Yang CS 2004 Modulation of arachidonic acid metabolism by curcumin and related β-dik- etone derivatives: effects on cytosolic phospholipase A(2), cyclooxygenases and 5-lipoxygenase. Carcinogenesis 25:1671-1679
14. Brown MD, Hart CA, Gazi E, Bagley S, Clarke NW 2006 Promotion of prostatic metastatic migration towards human bone marrow stoma by Omega 6 and its inhibition by Omega 3 PUFAs. Br J Cancer 94:842-853
15. Howe LR, Dannenberg AJ 2002 A role for cyclooxygenase-2 inhibitors in the prevention and treatment of cancer. Semin Oncol 29(Suppl 11):111-119
16. Ye LH, Wu LY, Guo W, Ma HT, Zhang XD 2006 [Screening of a sub-clone ofhuman breast cancer cells with high metastasis potential]. Zhonghua Yi Xue Za Zhi 86:61-65 (Chinese)
17. Ye LH, YouJC, Guo W, XuSF, WuLY, Qi RZ, Zhang XD 2006 [Investigation of discrepant proteins between two breast cancer cell lines with different met- astatic abilities]. Ai Zheng 25:823-827 (Chinese)
18. Ye YN, Wu WK, ShinVY, Bruce IC, Wong BC, Cho CH 2005 Dual inhibition of 5-LOX and COX-2 suppresses colon cancer formation promoted by cigarette smoke. Carcinogenesis 26:827-834
19. Zhou X, Lin Y, You J, Zhang X, Ye L 2008 Myosin light-chain kinase contributes to the proliferation and migration of breast cancer cells through crosstalk with activated ERK 1/2. Cancer Lett 270:312-327
20. Hazai E, Bikadi Z, Zsila F, Lockwood SF 2006 Molecular modeling of the non-covalent binding of the dietary tomato carotenoids lycopene and lyco- phyll, and selected oxidative metabolites with 5-lipoxygenase. Bioorg Med Chem 14:6859 -6867
21. Tong WG, Ding XZ, Witt RC, Adrian TE 2002 Lipoxygenase inhibitors attenuate growth of human pancreatic cancer xenografts and induce apoptosis through the mitochondrial pathway. Mol Cancer Ther 1:929 -935
22. Vang K, Ziboh VA 2005 15-lipoxygenase metabolites of γ-linolenic acid/ei- cosapentaenoic acid suppress growth and arachidonic acid metabolism in human prostatic adenocarcinoma cells: possible implications of dietary fatty acids. Prostaglandins Leukot Essent Fatty Acids 72:363-372
23. Wang J, Shen WH, Jin YJ, Brandt-Rauf PW, Yin Y 2007 A molecular link between E2F-1 and the MAPK cascade. J Biol Chem 282:18521-18531
24. Lengronne A, Pasero P, Bensimon A, Schwob E 2001 Monitoring S phase progression globally and locally using BrdU incorporation in TK(+) yeast strains. Nucleic Acids Res 29:1433-1442
25. Maeda M, Kato S, Fukushima S, Kaneyuki U, Fujii T, Kazanietz MG, Oshima K, Shigemori M 2006 Regulation of vascular smooth muscle proliferation and migration by β2-chimaerin, a non-protein kinase C phorbol ester receptor. Int J Mol Med 17:559 -566
26. Qin X, Zhang H, Zhou X, Wang C, Zhang H, Zhang X, Ye L 2007 Proliferation and migration mediated by Dkk-1/Wnt/β-catenin cascade in a model of hepatocellular carcinoma cells. Transl Res 150:281-294
27. Marusawa H, Matsuzawa S, Welsh K, ZouH, Armstrong R, Tamm I, Reed JC 2003 HBXIP functions as a cofactor of survivin in apoptosis suppression. EMBO J 22:2729-2740
28. Plas E, Carroll VA, Jilch R, Simak R, Miliary J, Melchior S, Thuroff JW, Binder BR, Pfluger H 2001 Variations of components of the plasminogen activation system with the cell cycle in benign prostate tissue and prostate cancer. Cy- tometry 46:184-189
29. Cowan KJ, Storey KB 2003 Mitogen-activated protein kinases: new signaling pathways functioning in cellular responses to environmental stress. J Exp Biol 206:1107-1115
30. Jun DJ, Lee JH, Choi BH, Koh TK, Ha DC, Jeong MW, Kim KT 2006 Sphin- gosine-1-phosphate modulates both lipolysis and leptin production in differentiated rat white adipocytes. Endocrinology 147:5835-5844
31. Kostenis E 2004 A glance at G-protein-coupled receptors for lipid mediators: a growing receptor family with remarkably diverse ligands. Pharmacol Ther 102:243-257
32. Paine E, Palmantier R, Akiyama SK, Olden K, Roberts JD 2000 Arachidonic acid activates mitogen-activated protein (MAP) kinase-activated protein ki- nase 2 and mediates adhesion of a human breast carcinoma cell line to collagen type IV through a p38 MAP kinase-dependent pathway. J Biol Chem 275:11284 -11290
33. Ripple MO, Kalmadi S, Eastman A 2005 Inhibition of either phosphatidyl- inositol 3-kinase/Akt or the mitogen/extracellular-regulated kinase, MEK/ ERK, signaling pathways suppress growth of breast cancer cell lines, but MEK/ ERK signaling is critical for cell survival. Breast Cancer Res Treat 93:177-188
34. Zivadinovic D, Watson CS 2005 Membrane estrogen receptor-α levels predict estrogen-induced ERK1/2 activation in MCF-7 cells. Breast Cancer Res 7:R130 -R144
35. Santen RJ, Song RX, McPherson R, Kumar R, Adam L, Jeng MH, Yue W 2002 The role of mitogen-activated protein (MAP) kinase in breast cancer. J Steroid Biochem Mol Biol 80:239 -256
36. Bocca C, Bozzo F, Francica S, Colombatto S, Miglietta A 2007 Involvement of PPAR γ and E-cadherin/β-catenin pathway in the antiproliferative effect of conjugated linoleic acid in MCF-7 cells. Int J Cancer 121:248-256
37. Kawano Y, Kypta R 2003 Secreted antagonists of the Wnt signalling pathway. J Cell Sci 116:2627-2634
38. Ding Q, Xia W, Liu JC, Yang JY, Lee DF, Xia J, Bartholomeusz G, Li Y, Pan Y, Li Z, Bargou RC, Qin J, Lai CC, Tsai FJ, Tsai CH, Hung MC 2005 Erk associates with and primes GSK-3β for its inactivation resulting in upregula- tion of β-catenin. Mol Cell 19:159-170
39. Jalal Hosseinimehr S, Inanami O, Hamasu T, Takahashi M, Kashiwakura I, Asanuma T, Kuwabara M 2004 Activation of c-kit by stem cell factor induces radioresistance to apoptosis through ERK-dependent expression of survivin in HL60 cells. J Radiat Res (Tokyo) 45:557-561
40. Altieri DC 2003 Survivin in apoptosis control and cell cycle regulation in cancer. Prog Cell Cycle Res 5:447-452
41. ChiouWF, Tsai HR, Yang LM, Tsai WJ 2004 C5a differentiallystimulates the ERK1/2 and p38 MAPK phosphorylation through independent signaling pathways to induced chemotactic migration in RAW264.7 macrophages. Int Im- munopharmacol 4:1329 -1341
42. Claria J, Romano M 2005 Pharmacological intervention of cyclooxygenase-2 and 5-lipoxygenase pathways. Impact on inflammation and cancer. Curr Pharm Des 11:3431-3447
43. Kirkpatrick K, Ogunkolade W, Elkak A, Bustin S, Jenkins P, Ghilchik M, Mokbel K 2002 The mRNA expression of cyclo-oxygenase-2 (COX-2) and vascular endothelial growth factor (VEGF) in human breast cancer. Curr Med Res Opin 18:237-241
44. Fulton AM, Ma X, Kundu N 2006 Targeting prostaglandin E EP receptors to inhibit metastasis. Cancer Res 66:9794-9797
45. Schroeder CP, Yang P, Newman RA, Lotan R 2007 Simultaneous inhibition of COX-2 and 5-LOX activities augments growth arrest and death of prema- lignant and malignant human lung cell lines. J Exp Ther Oncol 6:183-192
46. Martinez-Gonzalez J, Escudero I, Badimon L 2004 Simvastatin potentiates PGI(2) release induced by HDL in human VSMC: effect on Cox-2 up-regula- tion and MAPK signalling pathways activated by HDL. Atherosclerosis 174:305-313
47. Urquhart P, Parkin SM, Rogers JS, Bosley JA, Nicolaou A 2002 The effect of conjugated linoleic acid on arachidonic acid metabolism and eicosanoid production in human saphenous vein endothelial cells. Biochim Biophys Acta 1580:150 -160
48. Storch J, Thumser AE 2000 The fatty acid transport function of fatty acid- binding proteins. Biochim Biophys Acta 1486:28 -44